GENERATION BIO CO's ticker is GBIO and the CUSIP is 37148K100. A total of 88 filers reported holding GENERATION BIO CO in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,923,508 | -34.1% | 507,522 | -4.3% | 0.00% | – |
| Q2 2023 | $2,917,437 | +25.0% | 530,443 | -2.3% | 0.00% | – |
| Q1 2023 | $2,334,040 | -31.4% | 542,800 | -37.3% | 0.00% | – |
| Q4 2022 | $3,400,479 | +5.6% | 865,262 | +42.7% | 0.00% | – |
| Q3 2022 | $3,220,000 | +2267.6% | 606,458 | +2817.8% | 0.00% | – |
| Q2 2022 | $136,000 | -15.5% | 20,785 | -5.3% | 0.00% | – |
| Q1 2022 | $161,000 | -86.5% | 21,945 | -87.0% | 0.00% | – |
| Q4 2021 | $1,191,000 | +45.4% | 168,245 | +414.6% | 0.00% | – |
| Q3 2021 | $819,000 | +65.1% | 32,694 | +77.6% | 0.00% | – |
| Q2 2021 | $496,000 | -4.8% | 18,408 | +0.6% | 0.00% | – |
| Q1 2021 | $521,000 | +401.0% | 18,305 | +400.1% | 0.00% | – |
| Q4 2020 | $104,000 | +10300.0% | 3,660 | +10066.7% | 0.00% | – |
| Q3 2020 | $1,000 | – | 36 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Atlas Venture Life Science Advisors, LLC | 8,278,876 | $54,309,000 | 9.08% |
| Artal Group S.A. | 2,814,191 | $18,461,000 | 0.99% |
| HighVista Strategies LLC | 248,994 | $1,633,000 | 0.99% |
| Yiheng Capital Management, L.P. | 2,597,631 | $17,040,000 | 0.97% |
| PFM Health Sciences, LP | 2,773,313 | $18,193,000 | 0.69% |
| BVF INC/IL | 1,556,032 | $10,273,000 | 0.50% |
| HARVARD MANAGEMENT CO INC | 510,354 | $3,348,000 | 0.39% |
| Bellevue Group AG | 3,627,280 | $23,795,000 | 0.34% |
| FARALLON CAPITAL MANAGEMENT LLC | 2,897,300 | $19,006,000 | 0.10% |
| Corton Capital Inc. | 15,493 | $102,000 | 0.10% |